Early trial tests new diabetes pill combo in healthy people
Knowledge-focused
Completed
This early-stage study aimed to see how a new combination pill for diabetes (HD-P023) compares to taking two separate diabetes drugs (teneligliptin and empagliflozin) together. It involved 40 healthy adult volunteers to measure how the drugs move through the body and check for sa…
Phase: PHASE1 • Sponsor: Handok Inc. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC